RecruitingNCT06657248

Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

Prospective, Multicenter Study Evaluating the Midterm Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Knee Implant

Sponsor

Aesculap AG

Enrollment

150 participants

Start Date

Apr 2, 2026

Study Type

OBSERVATIONAL

Conditions

Gonarthritis Degenerative disease

Summary

The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called univation® XF Pro for people with degenerative disease and gonarthritis. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEunivation® XF Pro

Primary medial unicompartmental knee arthroplasty

Locations(4)

Oberlinklinik gGmbH

Potsdam, Brandenburg, Germany

Lukas Krankenhaus

Bünde, North Rhine-Westphalia, Germany

St. Vincenz Hospital Brakel

Brakel, Germany

LMU Großhadern

München, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06657248

Related Trials

Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage 2

NCT035862581 location

Thoracic-Lumbar Arthrodesis- Implanet Jazz

NCT053661401 location